Methyl CpG binding protein 2 (MeCP2) enhances photodimer formation at methyl-CpG sites but suppresses dimer deamination

被引:7
|
作者
Cannistraro, Vincent J. [1 ]
Taylor, John-Stephen A. [1 ]
机构
[1] Washington Univ, Dept Chem, St Louis, MO 63130 USA
基金
美国国家卫生研究院;
关键词
CYCLOBUTANE PYRIMIDINE DIMERS; ACID-SOLUBLE PROTEINS; ALPHA/BETA-TYPE SMALL; DNA-POLYMERASE-ETA; UV PHOTOPRODUCTS; P53; MUTATIONS; IN-VIVO; HYDROLYTIC DEAMINATION; THYMINE DIMERIZATION; HISTONE DEACETYLASE;
D O I
10.1093/nar/gkq582
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Spontaneous deamination of cytosine to uracil in DNA is a ubiquitous source of C -> T mutations, but occurs with a half life of similar to 50 000 years. In contrast, cytosine within sunlight induced cyclobutane dipyrimidine dimers (CPD's), deaminate within hours to days. Methylation of C increases the frequency of CPD formation at PyCG sites which correlate with C -> T mutation hotspots in skin cancers. MeCP2 binds to (m)CG sites and acts as a transcriptional regulator and chromatin modifier affecting thousands of genes, but its effect on CPD formation and deamination is unknown. We report that the methyl CpG binding domain of MeCP2 (MBD) greatly enhances C=(m)C CPD formation at a TC(m)CG site in duplex DNA and binds with equal or better affinity to the CPD-containing duplex compared with the undamaged duplex. In comparison, MBD does not enhance T=(m)C CPD formation at a TT(m)CG site, but instead increases CPD formation at the adjacent TT site. MBD was also found to completely suppress deamination of the T=(m)CG CPD, suggesting that MeCP2 may have the capability to both suppress UV mutagenesis at Py(m)CpG sites as well as enhance it.
引用
收藏
页码:6943 / 6955
页数:13
相关论文
共 50 条
  • [1] Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2)
    Valinluck, V
    Tsai, HH
    Rogstad, DK
    Burdzy, A
    Bird, A
    Sowers, LC
    [J]. NUCLEIC ACIDS RESEARCH, 2004, 32 (14) : 4100 - 4108
  • [2] Biological function of the methyl-CpG binding protein MeCP2
    Bird, A
    Guy, J
    Hendrich, B
    Free, A
    Ng, HH
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 : S15 - S15
  • [3] MeCP2 and other methyl-CpG binding proteins
    Jorgensen, HF
    Bird, A
    [J]. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2002, 8 (02): : 87 - 93
  • [4] DNA recognition by the methyl-CpG binding domain of MeCP2
    Free, A
    Wakefield, RID
    Smith, BO
    Dryden, DTF
    Barlow, PN
    Bird, AP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (05) : 3353 - 3360
  • [5] DISSECTION OF THE METHYL-CPG BINDING DOMAIN FROM THE CHROMOSOMAL PROTEIN MECP2
    NAN, XS
    MEEHAN, RR
    BIRD, A
    [J]. NUCLEIC ACIDS RESEARCH, 1993, 21 (21) : 4886 - 4892
  • [6] The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse
    Tate, P
    Skarnes, W
    Bird, A
    [J]. NATURE GENETICS, 1996, 12 (02) : 205 - 208
  • [7] Emerging chromatin structural roles of the methyl-CpG binding protein MeCP2
    Imaizumi, Yui
    Feil, Robert
    [J]. EPIGENOMICS, 2021, 13 (06) : 405 - 410
  • [8] MeCP2 binding to DNA depends upon hydration at methyl-CpG
    Ho, Kok Lian
    McNae, Lain W.
    Schmiedeberg, Lars
    Klose, Robert J.
    Bird, Adrian P.
    Walkinshaw, Malcolm D.
    [J]. MOLECULAR CELL, 2008, 29 (04) : 525 - 531
  • [9] Proteomic identification of co-factors for the methyl-CpG binding protein, MeCP2
    Tsujimura, Keita
    Suzuki, Akiya
    Fukao, Yoichiro
    Fujiwara, Masayuki
    Nakashima, Kinichi
    [J]. NEUROSCIENCE RESEARCH, 2010, 68 : E351 - E351
  • [10] Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome
    Obata, K
    Matsuishi, T
    Yamashita, Y
    Fukuda, T
    Kuwajima, K
    Horiuchi, I
    Nagamitsu, S
    Iwanaga, R
    Kimura, A
    Omori, I
    Endo, S
    Mori, K
    Kondo, I
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (08) : 608 - 610